Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 417,000 | 319,500 | 1,292,900 | 1,341,800 | 875,300 |
| Depreciation Amortization | 750,900 | 312,000 | 1,073,600 | 748,600 | 484,900 |
| Income taxes - deferred | -4,000 | 23,600 | 361,600 | 194,700 | -59,100 |
| Accounts receivable | -166,000 | -33,700 | 102,700 | 74,900 | -170,500 |
| Other Working Capital | -366,000 | -127,900 | -1,057,600 | -948,900 | -1,123,100 |
| Other Operating Activity | 462,500 | 152,000 | 431,400 | 281,600 | 412,700 |
| Operating Cash Flow | $1,094,400 | $645,500 | $2,204,600 | $1,692,700 | $420,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -92,100 | -51,200 | -153,800 | -109,900 | -63,700 |
| Net Acquisitions | -5,065,100 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -896,600 | -748,800 | -1,258,300 | -91,000 | 0 |
| Sale Of Investment | 2,140,900 | 625,700 | 79,700 | 56,600 | 0 |
| Purchase Sale Intangibles | -135,000 | 0 | -31,600 | -15,300 | -10,000 |
| Other Investing Activity | -135,800 | -35,200 | -38,700 | 4,900 | -40,600 |
| Investing Cash Flow | $-4,048,700 | $-209,500 | $-1,371,100 | $-139,400 | $-104,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,400,000 | N/A | 1,733,100 | 1,733,100 | 1,733,400 |
| Debt Repayment | -1,096,700 | N/A | -1,750,000 | -1,750,000 | -1,750,000 |
| Common Stock Issued | -49,100 | -55,100 | N/A | N/A | -18,200 |
| Other Financing Activity | -2,000 | 11,300 | -285,000 | -148,000 | 100 |
| Financing Cash Flow | $1,252,200 | $-43,800 | $-301,900 | $-164,900 | $-34,700 |
| Exchange Rate Effect | -21,400 | -18,000 | 101,900 | 99,400 | 102,600 |
| Beginning Cash Position | 3,008,500 | 3,008,500 | 2,375,000 | 2,375,000 | 2,375,000 |
| End Cash Position | 1,285,000 | 3,382,700 | 3,008,500 | 3,862,800 | 2,758,800 |
| Net Cash Flow | $-1,723,500 | $374,200 | $633,500 | $1,487,800 | $383,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,094,400 | 645,500 | 2,204,600 | 1,692,700 | 420,200 |
| Capital Expenditure | -92,100 | -51,200 | -153,800 | -109,900 | -63,700 |
| Free Cash Flow | 1,002,300 | 594,300 | 2,050,800 | 1,582,800 | 356,500 |